Evidence map›Paper›PMID 42065192›Full record

ArticleMedicine2026

Rare pathological types of gallbladder cancer: Cases report.

Hao Wang, Zepu Wang, Yang Zhao, Yaqi Xiang, Jun Li, Hongfang Tuo

Abstract readCase Reports
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hao WangGraduate School of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID 0009-0008-6386-9922
Zepu WangDepartment of Hepatobiliary and Pancreatic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China.
Yang ZhaoGraduate School of Hebei Medical University, Shijiazhuang, Hebei, China.
Yaqi XiangGraduate School of Hebei Medical University, Shijiazhuang, Hebei, China.
Jun LiDepartment of Hepatobiliary and Pancreatic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China.
Hongfang TuoGraduate School of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID 0009-0009-5658-6569

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleGallbladder cancer is one of the most aggressive malignancies in the biliary system, and there is currently no internationally recognized standardized treatment protocol. Reports on the management of rare pathological types of gallbladder cancer are particularly limited. We present 2 cases of gallbladder cancer with rare pathological subtypes and their diagnostic and therapeutic processes, aiming to further enhance clinicians' understanding of these uncommon entities. PATIENT CONCERNS: This report describes 2 cases of gallbladder cancer, both presenting with abdominal discomfort, raising concerns about the nature of the lesion and effective treatment strategies. DIAGNOSES: Postoperative pathology confirmed one case as gallbladder sarcomatoid carcinoma and the other as gallbladder carcinosarcoma, both of which are clinically rare types.

interventionsBoth patients underwent laparoscopic cholecystectomy at our institution, with subsequent pathological and immunohistochemical examination. OUTCOMES: As of the end of follow-up (November 30, 2025), both patients recovered well postoperatively. LESSONS: Rare types of gallbladder cancer lack specific clinical manifestations, making early screening difficult. Most patients are diagnosed at an advanced stage. Surgical intervention should be performed as early as possible upon discovery.

Indexed as

CarcinosarcomaGallbladder NeoplasmsAgedCholecystectomy, LaparoscopicFemaleGallbladderHumansMaleMiddle Agedgallbladder cancergallbladder carcinosarcomagallbladder sarcomatoid carcinoma

Identifiers

PMID42065192
PMCPMC13138445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.